Posted by SLS on June 29, 2014, at 7:55:29
In reply to Re: HNK - Ketamine metabolite as oral antidepressant, posted by linkadge on June 21, 2014, at 17:07:17
Hi Linkadge.
"HNK targets a specific subtype of the nicotinic acetylcholine receptors, the alpha-7 nicotinic receptor, that are located at the nerve junctions, while ketamine targets the N-methy-D- aspartate (NMDA) receptor, which is located throughout the body," Dr. Wainer explained. "The effect of ketamine on the NMDA receptor is the source of the drug's anesthetic activity as well as its unwanted side effects."
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1067148
URL: http://www.dr-bob.org/babble/20140609/msgs/1067593.html